|
Status |
Public on Apr 30, 2019 |
Title |
Rh30_siNR4A1/3_rep1 |
Sample type |
RNA |
|
|
Source name |
Rh30_siNR4A1/3
|
Organism |
Homo sapiens |
Characteristics |
cell line: Rh30 cell type: Rhabdomyosarcoma
|
Treatment protocol |
Rh30 rhabdomyosarcoma cells were transfected for 48 hours with 25 nM of Dharmacon ON-TARGETplus SMARTpool NR4A-specific siRNA or non-targeting siRNA alone or in combination (total of 75nM siRNA) using 6μL Lipofectamine RNAiMAX per well of a 6-well plate
|
Growth protocol |
Rh30 rhabdomyosarcoma cells were cultured in RPMI-1640 medium containing 10% fetal bovine serum at 37°C, 5% CO2
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted using Promega simplyRNA kit and Maxwell-16 following manufacturer's instructions
|
Label |
Cy3
|
Label protocol |
100ng of total RNA were labeled (Cy3) according to Agilent's labeling protocol
|
|
|
Hybridization protocol |
Microarray hybridization was performed at 65°C for 18 hours in Agilent's microarray hybridization chambers, followed by wash procedures according to the manufacturer’s recommended protocols
|
Scan protocol |
Microarray was scanned in an Agilent scanner at 3μm resolution, and the array data was extracted with Agilent feature extraction software using the GE1_107_Sep09 protocol
|
Description |
Gene expression after 48hr cotransfection with 25nM siRNA against NR4A1, 25nM siRNA against NR4A3, and 25nM non-targeting siRNA, biological replicate 1
|
Data processing |
Agilent Feature Extraction Software (version 10.5.1.1) was used along with LOWESS normalization
|
|
|
Submission date |
Apr 30, 2015 |
Last update date |
Apr 30, 2019 |
Contact name |
Yong-Dong Wang |
E-mail(s) |
michael.wang@stjude.org
|
Phone |
9015954224
|
Organization name |
St. Jude Children's Research Hospital
|
Street address |
262 Danny Thomas Pl, MS1135
|
City |
Memphis |
State/province |
TN |
ZIP/Postal code |
38134 |
Country |
USA |
|
|
Platform ID |
GPL14550 |
Series (1) |
GSE68458 |
Analysis of NR4A-specific gene expression in human alveolar rhabdomyosarcoma in response to specific gene knockdown |
|